Table 3. The relationship between GALNT6 expression and clinicopathological parameters.

	GALNT6 expression of cohort from TCGA, n (%)			GALNT6 expression of TMA cohort, n (%)
	Low (522)	High (521)	p-value	Low (65)	High (71)	p-value
Age (years)			0.113			0.932
Median (range)	56 (26-90)	59 (26-90)		51 (31-82)	53 (29-83)
T stage			0.266		0.802
T1	131 (25.1)	138 (26.5)		12 (18.6)	16 (22.5)
T2	327 (62.6)	285 (54.7)		47 (71.4)	47 (66.2)
T3	50 (9.6)	84 (16.1)		6 (10.0)	8 (11.3)
T4	14 (2.7)	14 (2.7)
N stage			0.033			0.004
N0	273 (52.3)	238 (45.7)		30 (41.4)	20 (28.2)
N1-3	249 (47.7)	283 (54.3)		35 (58.6)	51 (71.8)
TNM stage			0.091		0.029
I	87 (16.7)	92 (17.7)		4 (6.2)	6 (8.5)
II	330 (63.2)	286 (54.9)		46 (70.8)	33 (46.5)
III	105 (20.1)	143 (27.4)		15 (23.1)	32 (45.1)